Delivery Order SPE2DB20D1004-SPE2DB24FF4D7
Award Date
2/14/24
Potential Completion Date
2/15/24
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA). The $2,840.23 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of November 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA). The $1,057 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of March 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablets to the Defense Logistics Agency (DLA). The $9,845.90 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. This $7,010.86 delivery order was awarded on April 27, 2023, with a completion date of April 28, 2023. The contract has a firm fixed price pricing type and is not designated with any set-aside requirements, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Micardis HCT 80-12.5 mg tablet units. The award, valued at $6,060.65, is a firm fixed-price delivery order contract with a completion date of March 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of MICARDIS HCT 80-12.5 mg tablets. The $10,954.37 firm-fixed-price delivery order has a completion date of May 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly...
This federal contract award is for pharmaceutical products and medical supplies provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $11,347.43 delivery order contract with the Defense Logistics Agency (DLA) is for Micardis HCT 40-12.5 mg tablets and has a completion date of May 3, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a Delivery Order valued at $2,000.11 for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of November 8, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating the contract was awarded through full and open competition. Amerisourcebergen...
This federal contract award is for the supply of Micardis HCT 80-25 mg tablets by Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The $2,463.75 firm fixed-price delivery order has a completion date of July 25, 2024. The contract is not set aside for any special designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, including a $999,999,999 IDC with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,004.76 Firm Fixed Price delivery order is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of December 22, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...